Gliogenesis around lesion site

"Gliogenesis around lesion site" is not the name of a specific molecule, receptor, or canonical drug target. Instead, it refers to the **biological process** by which new glial cells—such as astrocytes and oligodendrocytes—are generated in the nervous system, particularly in response to injury or lesions[3][4][5]. After central nervous system damage, gliogenesis contributes to scar formation and tissue remodeling at the lesion border. This involves migration and differentiation of progenitor cells from regions like the subventricular zone into astrocytes that participate in forming a glial scar[1]. The molecular signals driving this process include cytokines activating pathways such as JAK/STAT, bone morphogenic proteins (BMP), Notch signaling, and transcription factors like SOX9 and NFIA[2]. However, "gliogenesis around lesion site" is not itself a therapeutic target but rather describes an important reparative mechanism following neural injury. Because this entry does not correspond to a single defined protein/receptor/enzyme/transporter/etc., it should be flagged as incorrect for structured drug-target databases.

Other names

GliogenesisGlial cell generationGlial cell formation